DRAFT — For Practitioner Review Only Version 0.2 · July 2026 · Injector Series · Not for clinical use or distribution beyond this review cohort
Injector Series — INJ.01

Neuromodulators: clinical framework & the 5 D’s

A structured clinical approach to botulinum toxin type A treatment — from muscle diagnosis through to distribution — treating facial musculature as an interconnected system rather than a set of isolated targets.

5 units ~8 min each 14 checkpoints Level: Injector (RN / Medical) TGA compliant
Your progress 0 of 14 checkpoints committed
Unit 1 Mechanism & Foundations How BTX-A works at the neuromuscular junction, why the effect is temporary, and the clinical timing that follows from it. 3 checkpoints · ~8 min Not started Unit 2 Diagnosis & Dose The 5 D’s framework, dynamic and static assessment, muscle strength grading, and dose reasoning by treatment area. 3 checkpoints · ~8 min Not started Unit 3 Depth, Direction & Distribution Muscle planes and needle selection, entry angle and the supraorbital safety corridor, diffusion radius and dilution. 3 checkpoints · ~8 min Not started Unit 4 The Interconnected System Elevators against depressors, four clinical scenarios, and when treating the whole system is the wrong call. 3 checkpoints · ~8 min Not started Unit 5 Muscle Map & Synthesis The interactive muscle map as a working planning tool, plus an integrative case drawing the five principles together. 2 checkpoints · ~8 min Not started

Each unit follows the same rhythm: a short piece of clinical content, a checkpoint that asks you to commit to an answer, then the reasoning behind it. Checkpoints are not scored and cannot be retried — committing to a position before seeing the answer is the point of the exercise. Your progress is stored on this device only.

Prerequisite. This module assumes foundational facial anatomy knowledge. If you have not completed Module 03.01 — Facial Muscle Anatomy, completing that first is strongly recommended.